Bharat Biotech's Covid-19 vaccine Covaxin gets mixed review from Lancet - Dealers Care

Breaking

BANNER 728X90

Thursday, 11 November 2021

Bharat Biotech's Covid-19 vaccine Covaxin gets mixed review from Lancet

Extrapolating from the report, Lancet said 'two doses offer 77.8 per cent protection against symptomatic Covid-19'.

from Latest News https://ift.tt/30lXoWr

No comments:

Post a Comment

loading...